Skip to content

Synergy CHC Corp.

SNYRQ · OTCM

CIK 1562733fmd_0SX9JQ1A5Y52ZZJC487EAMPDVFManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Aug 01, 2011 to Mar 31, 2026, 50 periods

Income Statement · Annual · Millions · USD
Line itemFY2014FY2015FY2016FY2017FY2018FY2019FY2022FY2023FY2024FY2025
Total revenues01335363429–433530
Net interest income–(0)––––––––
Net investment income––––––––––
Cost of revenue051010119–111110
Gross profit0825262320–322420
Selling, general and administrative–718222517–211822
Total operating expenses1822242828–211829
Operating income(1)032(5)(8)–116(8)
Interest expense0(1)(2)11–2226
Interest and investment income–––––––000
Other non-operating income (expense)083111–(4)(4)(4)
Income before taxes(1)(7)01(6)(9)–72(12)
Income tax expense00100(0)–000
Net income from continuing operations(1)(8)(1)0(7)(9)–62(12)
Net income(1)(8)(1)0(6)(9)–62(12)
Synergy CHC Corp. (SNYRQ) financial statements · FinancialMD